IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
45 hedge funds and large institutions have $132M invested in Impel Pharmaceuticals Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
41% less capital invested
Capital invested by funds: $222M → $132M (-$90.7M)
Holders
45
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.8M | |
| 2 | +$1.23M | |
| 3 | +$1.1M | |
| 4 |
DA
DCF Advisers
Greenwich,
Connecticut
|
+$915K |
| 5 |
BlackRock
New York
|
+$745K |
Top Sellers
| 1 | -$3.78M | |
| 2 | -$2.44M | |
| 3 | -$1.69M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.22M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$979K |